Talk therapy and medications have been the bedrock of mental health care for a century, and help millions of Americans of all ages every year.
But for people whose condition does not improve after trying these options, there are new and emerging options to consider.
This free online talk will feature Michigan Medicine experts discussing four of them – three based in targeted stimulation of key areas of the brain using impulses delivered from outside the head, and one involving a medication that can be injected or inhaled. These forms of “interventional psychiatry” have shown promise for treatment-resistant depression and bipolar disorder, and other conditions. Some have received U.S. Food and Drug Administration approval and are covered by many types of insurance, while others are still experimental and can be accessed through clinical trials.
They are all available at Michigan Medicine’s Department of Psychiatry. The talk will cover Transcranial direct current stimulation (tDCS), Transcranial Magnetic Stimulation (TMS), Ketamine Infusion Therapy, and Electroconvulsive Therapy (ECT). Additionally, the potential for use of psychedelic substances in psychiatric treatment will be briefly discussed, though this is not yet available at Michigan.
Panelists:
Dr. Ben Hampstead will discuss tDCS
Dr. Steve Taylor will talk about TMS
Dr. Sagar Parikh will speak about Ketamine
Dr. Shami Entenman will present on ECT
ECT patient Heather S. will share her story
More information:
TMS:
ECT:
- ECT: The final (essential) option
- Electroconvulsive therapy: Peeling back the mystery
- Video: ECT: Disrupting the Stigma Around An Essential Treatment Option
Ketamine:
- Our Ketamine Clinic
- Ketamine Infusion Therapy brochure
- Listening to Ketamine
- Depression: Finding What Works for You
Brain stimulation to slow cognitive decline:
